Frost.com - Healthcare Research http://www.frost.com/c/10024/home.do http://www.frost.com/c/10024/home.do - Healthcare Research Frost & Sullivan Innovations in Medical Devices in Bioelectronics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0D-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0D-00-00 The latest issue of the Medical Device TOE showcases innovations in the field of bioelectronics. Typically, the products are miniature implantable devices or patch-based systems that can deliver micro-currents to the target neural system. Technologies that have been showcased in this edition use electrical pulses to stimulate neural cells to managed and treat conditions such as migraines, hypertension, inflammatory disease, and obesity. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Bioelectronics, neurostimulation, implantable devices, neuromodulation Fri, 20 Jan 2017 00:00:00 +0000 Cellular Therapy Innovations in Asia http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-36-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-36-00-00 This edition of Genetic Technology TOE depicts trends in cellular therapies across Asia. Cell therapies enable to address a broad spectrum of health concerns associated to multiple disease areas. The corresponding patent scenario for stem cell therapeutics is depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cell therapy, cellular therapy, mesenchymal stem cells, T-cell therapies, regenerative medicine, stem cell therapeutics Fri, 20 Jan 2017 00:00:00 +0000 Global Precision Medicine Growth Opportunities, Forecast to 2025 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0E6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0E6-01-00-00-00 Precision medicine aims to integrate personalized health data both from direct (quantifiable) and indirect (quantifiable) sources probing the deepest mysteries affecting individual health and well-being. Rising pressures to decrease healthcare cost globally, emergence of value-based reimbursement models, and healthcare digitization trends are transitioning the treatment model from One-size-fits-all to stratified and outcome-based targeted therapies called precision medicine. In the past few decades, our scientific knowledge and technological advancements around genomics has increased exponentially, making cost and time no longer a barrier for population-level genome profiling. Integration of these genomic and lifestyle data into clinical workflow to derive deeper insight into genetic and chronic deceases is unique to the precision medicine concept. However, the precision medicine concept is a nascent one that needs further refinement at fundamental levels with incremental progress towards more effective and targeted drugs that are precisely accurate in reducing the treatment uncertainty, to ultimately revolutionize the care delivery model in the long run. Also, the current legal and ethical frameworks both at global and regional levels were built with a very different generation of medical products and practices in mind and raise some serious challenges for the revolutionary concept of precision medicine practice. Research Scope: The research service analyzes the key building-blocks for precision medicine ecosystem to provide strategic imperatives and growth opportunities for key industry participants. The study also captures both global and regional flavours for precision medicine market opportunity realization such as market projections, drivers and restraints, country readiness index, and major government and commercial initiatives. Finally, the study provides live case studies and innovative business models for leading select companies in the precision medicine space. Key Questions This Study Will Answer: What is Precision Medicine and its impetus for the healthcare industry? What does the precision medicine ecosystem look like? Who are the key stakeholders and what are their roles? What are the current gaps in the precision medicine ecosystem and how can these be filled by industry partners? How big is the precision medicine market? What are the growth opportunities by major therapeutic areas, market segments, and technologies? What are the major market drivers and restraints for the precision medicine market and what are their use cases? Which countries demonstrate the highest growth opportunities for precision medicine? How are the regulatory and reimbursement landscapes evolving across these countries? What are the most promising business models emerging in the healthcare space to enable precision medicine practice? What are the strengths of my business against competition? Are these strengths sustainable over the next 5-10 years? What winning and losing strategies can be gleaned from the existing market case studies and companies to watch? Wed, 18 Jan 2017 00:00:00 +0000 Diagnosing the State of Medical Imaging in the United States: Perspectives from RSNA 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297227474 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297227474 Two months ago, Chicago, the windy city, played host once again to the Radiology Society of North America (RSNA) conference. Like previous years, the conference brought together industry participants, regulators, academics, medical professionals. Mon, 16 Jan 2017 00:00:00 +0000 Technologies Enabling Precision Medicine-based Drug Discovery http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0D-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0D-00-00 This edition of the Drug Discovery TOE assesses the potential of drug discovery technologies that are enabling the era of precision medicine. Customization of microfluidic properties for the development of organ on a chip technologies are improving target identification and validations extensively. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Microfluidic system, humanization, kinase inhibition, single cell research, selective inhibition, target identification Fri, 13 Jan 2017 00:00:00 +0000 Recent Advances in Immunology http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-35-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-35-00-00 This edition of Genetic Technology TOE depicts trends across immunology. The recent findings in genetics are likely to support novel approaches toward the management of immunity and may have a significant impact across target discovery in the near future. The corresponding patent scenario is depicted, along with the industry interactions. . The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Immunology, genetic technologies, genetics, amyloid-beta peptide, noninvasive vaccination, immunity assessment, vaccination efficacy, immune response Fri, 13 Jan 2017 00:00:00 +0000 Future of Behavioral Healthcare Paradigms, Forecast to 2022 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K12C-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K12C-01-00-00-00 The annual global cost of mental illnesses is set to rise to a whopping $6 trillion in 2030, from $2.5 trillion in 2010. Furthermore, the global treatment gap in 2004 for disorders such as depression and anxiety was more than 50% (half of the patients went untreated). Unfortunately, the situation has still not changed significantly. A growing body of evidence suggests that mental and physical health are fundamentally linked, indicating the need for holistic treatment approaches to include behavioral health for better patient outcomes. This research service analyzes the behavioral health market, its drivers such as the emergence of digital health technologies and gradually improving awareness, as well as restraints such as reimbursement issues and cultural stigma which prevent its growth. New focus areas in the care continuum are prevention (recognizing early symptoms and preventing worsening of the disease) and recovery (ensuring treated patients become productive members of the society). This study also assesses how treating the patients physical as well as behavioral health issues together will become the new model of integrated care delivery. Thu, 12 Jan 2017 00:00:00 +0000 Custom Procedure Trays and Packs in Western and Eastern Europe, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC7C-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC7C-01-00-00-00 This research service presents a detailed analysis of the European Custom Procedure Trays and Packs (CPTP) market. It provides an in-depth analysis of the market size, revenue forecast, overall as well as by surgical custom procedure trays and packs and minor procedure trays and packs and by packaging type (boxes, wraps and moulds). The surgical segment comprises nine specialty areas cardio-vascular; Ear, nose, and Throat (ENT); general and abdominal surgery, including laparoscopy; obstetrics and gynecology; neurosurgery; ophthalmology; orthopedics; plastic surgery; and urology packs and trays. The minor procedures segment comprises eight specialty areas angiography; antiseptic skin preparation; catheterization; hemodialysis; perfusion and IV therapy; regional anesthesia, suturing; and wound care packs and trays. The regional scope includes Western Europe (Germany, United Kingdom, France, Spain, Italy, Benelux, and Scandinavia) Eastern Europe (Bulgaria, the Czech Republic, Hungary, Poland, and Romania). Tue, 10 Jan 2017 00:00:00 +0000 Advancements in Microbiome and Genetics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-34-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-34-00-00 This edition of Genetic Technology TOE profiles trends across microbiome and genetics advancements. Microbiome science is an emerging arena that has impacted various segments. Skin health, gastrointestinal health, and supplemental health are all areas that would truly benefit from the products that can activate the human microbiome. Microbiome modulation using drugs could stimulate latent mechanisms to work effectively within the human body. Once these parameters are stimulated, enormous health benefits can be achieved. The TOE depicts the corresponding patent scenario, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Microbiome, genetics, sampling technology, gastrointestinal biomarkers, functional genomics, microbiome-based treatments, lactose intolerance, genetic testing Fri, 6 Jan 2017 00:00:00 +0000 Potential Impact on Health IT as US Adjusts to Republican Sweep in Election 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297194637 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297194637 The stunning outcome of the 2016 presidential election has left us long on questions and short on detail as to what this decisive win portends for healthcare markets in general and health IT specifically. Mon, 2 Jan 2017 00:00:00 +0000 Western European Molecular Diagnostics Market, 2015 Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC62-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC62-01-00-00-00 Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend . However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside of their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics Companies who fail to capitalize on opportunities presented through emerging trends and disruptive new business models become late entrants in a market that generally before redundancy from me-too products occurs and takes market share. This report is an elaborate structure of the European Healthcare system , which is supporting the growth of Molecular diagnostics , the reimbursement strategies and policies promoting the acceptance of MDx assays across application , This information would be suitable to understand the current need and the diagnostics style adaptation among the patient population for better outcome and clinical decision making. Specific challenges shared in this report include shifting payment landscape (business models) who pays for services, challenge monetize Innovative Therapeutics & Molecular Diagnostics to align with Value based Care Models Mon, 2 Jan 2017 00:00:00 +0000 Recent Advances in Genomic Techniques across the United States - Genetic TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-33-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-33-00-00 This edition of Genetic Technology TOE profiles trends in genomic techniques across the United States. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Genomic techniques, sequencing tool, gene networks, molecular tags, genetic marker-based assay, metastatic cancer, anti-sense therapy, KRAS Mutations Fri, 30 Dec 2016 00:00:00 +0000 Key Innovation Profiles in Medical and Diagnostic Imaging in UK - Medical and Diagnostic Imaging TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-0F-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-0F-00-00 This edition depicts medical and diagnostic and imaging innovations in UK. Quantitative reading software, medical scanner to augment 3D bio-printing, radiowave radar technology for imaging breast cancer, non-invasive imaging approach for detection of prostate cancer, oxygen-enhanced MRI for lung diseases, intra-cellular ultrasound imaging, PACS system for National Health Services (NHS) and optical with gamma combination imaging systems as an hybrid imaging modality have been profiled. Insights on future growth prospects for each of the innovation profiled is also provided along with the industry interactions. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Quantitative image reading, 3D bio-printing, radiowave radar technology, oxygen-enhanced MRI, intra-cellular ultrasound imaging, PACS system, hybrid imaging, optical and gamma combination imaging systems Fri, 30 Dec 2016 00:00:00 +0000 Israeli Technologies Impacting the Global Medical Sector http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A4-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A4-01-00-00-00 Over the past two decades, Israel had risen to be an global medical devices innovation hub, reinforcing its position as one of the major contributors to the growth of the innovations in the global medical devices sector. With a plethora of scientific resources, ease of conducting clinical research studies, globally competitive intellectual portfolio management practices, access to global investor networks, inclusion of a collaborative work culture and extensive knowledge in commercializing cutting-edge technologies, Israel is one of the countries that has found profound success in devising safe and effective therapies for addressing debilitating medical disorders. This research service evaluates the commercial impact and stakeholder strategies for top medical devices technologies in Israel, which include neuroprostheses, X-eluting stents, smart pills, surgical robotics, surgical lasers, and neuromodulation therapies. The following questions are answered in this report: 1. Who are the various innovation stakeholders (such as technology developers, clinical researchers and investors) in Israel that enable its development as a global innovation hub for medical devices? 2. What is the intensity of commercialization efforts that are happening across major cities (regional innovation hubs) of Israel namely, Tel Aviv, Jerusalem, Haifa, Yokneam, Ra'anana, Herzliya, Beer'Sheva, and Cesaerea? 3. Identifying the competencies of regional innovation hubs in Israel to sustainable innovate cutting-edge medical device technologies. 4. What are the strategic gaps that exist in the existing innovation ecosystem in Israel, and how commercial opportunities available for innovators in both Israeli and global players span out near-to-far term investments in Israel medical devices sector? 5. What are the strategic recommendations of analysts to stakeholders when evaluating early investment opportunities in Israel's medical devices sector? 6. Gather additional knowledge and recommendations in evaluating commercial partnership initiatives such as cross-selling agreements, in-organic growth initiatives such as acquisition or merger of Israeli firms, and regional/international collaborations on clinical trials. 7. How is the patent landscape in Israel for top medical device technologies? Why global companies hold most regional patents, and Israeli-based firms holding patents in matured medical device markets (especially in the USA and Europe)? Fri, 30 Dec 2016 00:00:00 +0000 3D Printing for Healthcare Applications http://www.frost.com/prod/servlet/sublib/display-report.do?id=D75D-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D75D-01-00-00-00 3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher s podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry. Fri, 30 Dec 2016 00:00:00 +0000 MGMA conference reveals range of medical practice struggles in optimizing IT-enabled care http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297188466 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297188466 Frost & Sullivan was in attendance at the MGMA conference held in early November in San Francisco. This is an annual conference primarily targeted to medical practice stakeholders including CXOs, administrators, physicians, nurse practitioners, and also healthcare IT vendors enabling value-based care for medical practices. Thu, 29 Dec 2016 00:00:00 +0000 Electronic Skin - Advancements and Emerging Opportunities http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A0-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A0-01-00-00-00 Electronic skin, otherwise known as e-skin or artificial skin is an ultrathin electronic material developed by integrating electronic devices on flexible and stretchable substrates. E-skin is an emerging and an advanced technology which is primarily intended for health monitoring and medical applications, such as measuring and sensing of internal vital sign activities in the body. E-skin has created footprint in consumer electronics and robotics markets. In the consumer market, e-skin is expected to replace existing body worn wearable devices, thus leading to creation of a new user interface device for controlling external electronic devices. E-skin has the potential to have high impact on robotics applications due to their ability to provide sense of touch. The technology and innovation report discusses about emerging opportunities in e-skin. It captures advancements and impact of current and future applications. Modules covered in the report include: Technology Status and Segmentation Application Landscape Key Innovations and Impact on Key Application Segments Patent Assessment and Funding Scenario Technology Roadmap and Emerging Opportunities Key Questions for Strategy Planning Thu, 29 Dec 2016 00:00:00 +0000 Utility of Video Telemedicine Solutions for Strengthening Healthcare in Africa http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183302 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183302 Frost & Sullivan s individual analysis, Enabling eHealth Technology in South Africa, Kenya, and Ghana , indicates that in Africa, governments and providers are adopting tele-healthcare tools (such as video telemedicine) in order to facilitate easily accessible healthcare to remote and rural regions. Tue, 27 Dec 2016 00:00:00 +0000 Trends Affecting the Healthcare IT Market in Western Europe http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183329 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183329 Frost & Sullivan s individual analysis, Western Europe Hospital Information Technology Outlook, 2016 2020 , indicates that the Healthcare IT market of Western Europe (covering nations such as the United Kingdom, Germany, France, Italy, Spain, Belgium, the Netherlands, Luxembourg, Sweden, Denmark and Norway) is undergoing tremendous changes with the advent of emerging digital health technologies Tue, 27 Dec 2016 00:00:00 +0000 Global Care Assistance and Automation Robots Market, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0F6-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0F6-01-00-00-00 The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime reason for successive adoption of care robots in the healthcare industry. Human-robot collaborations are expected to achieve breakthrough revolution in hospital and home-care settings. From carrying daily products such as medical waste, linen, lab reports, and meals to dispensing medicines and IV supplies, robots have the capability to significantly automate and impact hospital workflows, thereby improving productivity and, ultimately, quality of care. This study includes a detailed description of care assistance and automation robots and their sub-segments: daily care and transportation, telepresence and rehabilitative, pharma automation, and exoskeleton robots. The research also consists of detailed analysis of the current estimated market (2016) and market forecasts (2017 2021) of care assistance and automation robots and the sub-segments, description of various types of companies in this market, the future potential growth scenarios, and price points of each sub-segment. The study wraps up with key conclusions and a brief snapshot of strategies for succeeding while building a robots-for-hospital business model. Key objectives address the following questions: What are the current use cases of care assistance and automation robots within the healthcare sector? What barriers and challenges are care robots currently facing towards adoption? What are the market drivers? What are the current use cases for robots from various sub-segments of the care assistance and automation market? What will be the care assistance and automation robots market scene in the next five years? What are the market estimations and projections? Who are the current participants in the market ecosystem with solutions for varying applications within the healthcare industry? Mon, 26 Dec 2016 00:00:00 +0000 APAC Home Health Monitoring Market, Forecast for 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P918-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P918-01-00-00-00 APAC s home health monitoring market is set to generate nearly $2.2 billion by 2020. Local and international vendors should identify the long-term market progression and opportunity within home monitoring for both acute and chronic care in this region. APAC is shifting from centralized to decentralized models due to the need for efficient care delivery models. A combination of technological advances and regulatory overhaul across the region will enable innovative care delivery models, especially for managing chronic and life-style related diseases that will drive the demand for platform-based home monitoring solutions over the next five years. There is a concomitant increase in demand for remote patient monitoring (RPM) devices in the home but the adoption has not been as strong. Healthcare stakeholders in this region have also formed consortiums and are investing in pilots to generate data to build a funding model. Collaborated initiatives, such as Australia s National Telehealth Home Monitoring, South Korea s National Telehealth Demonstration Project, or Singapore s National Cardiac Monitoring are set to expand the market for home health monitoring. Technology-savvy societies like Japan, Singapore and Australia are already investing in population-level pilots while private healthcare providers in emerging markets like India are introducing platform-based home health solutions to niche customer segments. Integrated home monitoring platforms include devices offered through extremely flexible and lucrative payment plans, while money is made on clinical services provided through the data captured. The market is shifting focus from stand-alone devices to comprehensive remote patient monitoring platforms for end-to-end chronic disease management. Failure to accept the transformation by changing the current business model will result in inability to monetize, though the market is packed with opportunities yet to be explored. Vendors will struggle choosing the right business model to push their products to the market. This study analyzes the APAC market for home monitoring devices, sensors, wearables and mHealth apps as well as successful business models in this space and some innovative collaborations. Key Questions This Study will Answer What is the current state of home monitoring in APAC? How will it evolve until 2020? What are the most promising applications of home monitoring across therapeutic areas? What are the current technology and usage trends in the market? How will these evolve until 2020? How will the structure of the market change with time? What are the current sales channels and will these changes to offer better access in the future? What are the business models that are disrupting the market? Mon, 26 Dec 2016 00:00:00 +0000 eHealth to Strengthen Delivery of Care for Non-Communicable Diseases in Africa http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC78-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC78-01-00-00-00 eHealth to Strengthen Delivery of Care for Non-communicable Diseases in Africa Narrowing the Accessibility Gap through Partnerships, Growth Opportunities Created by Increased Disease Prevalence This study aims to analyse the eHealth market in Africa and its application in the mitigation of non-communicable diseases (NCDs). The major focus is on market trends (mHealth, wearables, and video telemedicine) and regional trends (Southern Africa, East Africa, West Africa, North Africa, and Indian Ocean Islands), focusing on the main competitors in each region. The major NCDs include various types of cancer, diabetes, respiratory diseases, and cardiovascular diseases. Mental health diseases are also noticeably growing in the continent. Africa s healthcare systems continue to struggle to adequately cater to the growing population, worsened by a high incidence of poverty in most parts. Low-resource communities bear the brunt of NCDs, as treatment is often costly. This then results in an increase in premature deaths as several individuals go untreated either due to lack of finances or late detection. However, as the economic growth rate is on an upward trajectory in many nations, the need for the improvement of healthcare facilities, IT systems, and infrastructure becomes more apparent. As the populations become more economically enabled, changes in lifestyle begin to be noticed. Smoking, excessive drinking, physical inactivity, and excessive salt/sodium intake are some of the negative lifestyle activities associated with prosperous and prospering nations, and NCDs. Also, the disease burden continues to increase for both communicable and non-communicable diseases, requiring new technology to manage populations. This study looks at the market leaders in each African region and how East Africa is leading the revolution as well as Southern Africa, with a focus on mHealth, wearables, and video telemedicine. These regions are led by Kenya and South Africa, respectively. The disease categories in this study are cardiovascular, cancer, diabetes, and respiratory the 4 largest NCD classes, responsible for over 80% of the NCD deaths around the globe. The main drivers and restraints of the market are highlighted in this study along with cross-country healthcare and IT trends. It proposes the growth opportunities available for companies and other eHealth stakeholders in implementing and improving eHealth in Africa as well as future perspectives. Key Questions This Study Will Answer: 1. Why is eHealth important for Africa? 2. What are the main eHealth markets, segments, and regions? 3. What are the main drivers and restraints for the eHealth market in Africa? 4. What are the utilities of eHealth in mitigating non-communicable diseases in Africa? 5. What are the growth opportunities in the African eHealth markets? 6. Which key companies are set to lead the market for eHealth? Thu, 22 Dec 2016 00:00:00 +0000 Innovations in Implantable Electronics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A3-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A3-01-00-00-00 The technology and innovation study on implantable electronics captures active implantable medical devices used for support of debilitating function in the human body or to completely replace the function of the diseased organ. The segments covered include: cochlear implants, retinal implants, implantable continuous glucose monitoring (CGM), implantable infusion pumps, cardiovascular implantable electronic devices, and implantable neurostimulation. Recent innovations and key innovators are captured under each segment. The study also covers reimbursement scenario of each of these devices in North America, Europe and Asia-Pacific. Regulatory framework and insurance coverage are considered to be the key factors that can lead to the successful growth of the implantable electronics market. Global patent scenario and key factors (drivers and challenges) influencing adoption have been identified. To aid C-level executives in strategic planning, technology convergence and growth opportunities (based on varied criteria such as business models and new capabilities) are captured in the study. Thu, 22 Dec 2016 00:00:00 +0000 African Pharmaceuticals Market, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC24-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC24-01-00-00-00 The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period. The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.--BEGIN PROMO--


Africa is in a transition phase, on its way to achieving adherence to global standards, such as the WHO pre-qualification for manufacturing. Local production is regarded as a key strategy for sustained access to quality-assured medicines for the long term. The regulatory environment for manufacturing in regions such as East Africa seems to grow rapidly, owing to regional harmonisation. Healthcare coverage is expected to expand to a greater proportion of the population through National Health Insurance (NHI) initiatives, as well as through memberships with private health insurance providers, particularly among the emerging middle class.

South Africa remains as the best established region for pharmaceutical manufacturing in sub-Saharan Africa. However, the local manufacturing markets in East and West Africa are relatively well developed and positioned to grow. A bulk of Africa-based pharmaceutical companies that are developing medicines have simple formulations and mixtures, which are easy to do. Technology transfer is paramount to developing the manufacturing sector in Africa, particularly as the disease burden is changing. There is a paradigm shift coming from the lower end to the higher end of adoption of complex formulations, in line with treatment guidelines, especially in HIV and AIDS and NCDs.

This research service presents findings on 2 fast-growing pharmaceutical markets in sub-Saharan Africa: Kenya and Nigeria. A brief competitive overview, along with the pricing and regulatory environment is provided for each country. Revenues and growth forecasts, insights on market dynamics, and drivers and restraints for the pharmaceutical markets of Kenya and Nigeria are covered. Market segmentation is done based on products (prescription—branded and generic and consumer care/over the counter) as well as therapeutic areas (haematology, oncology, men's health, central nervous system (CNS), women's health, diabetes, cardiovascular, dermatological, gastrointestinal, cough and cold, nutritional, analgesics, and anti-infectives).The study also provides the business opportunities and strategic recommendations for the pharmaceuticals market.

Wed, 21 Dec 2016 00:00:00 +0000
Funding Analysis of Emerging Microelectronics Technologies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D79B-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D79B-01-00-00-00 The objective of this research service is to cover the funding landscape of key emerging microelectronics technologies, viz., wearables, printed and flexible electronics, and brain-computer interface (BCI). Wearables have experienced a lot of interest from diverse fields and there have been a lot of developments worldwide. Various established companies and start-ups are constantly innovating to gain a foothold in this market. Flexible and printed electronics has shown a lot of potential to enable low cost mass manufactured products using printing technologies. However, manufacturing bottlenecks has hindered the adoption of the technology. It is expected that these challenges will be resolved in the near term as various companies are ramping up production to meet increasing demands. The research report covers funding initiatives from government, venture capital investment, and crowdfunding. It also covers key mergers and acquisition (M&As) activities and analyses its impact. The research report also captures key trends and technology roadmaps; it also assesses gaps in funding that needs to be addressed. Wed, 21 Dec 2016 00:00:00 +0000 Market Analysis of Emerging Cardiac Therapies in the United States and Western Europe, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC02-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC02-01-00-00-00 The biggest challenge for emerging cardiac procedures is adoption barrier and reimbursement. The long-term clinical evidence gathered through clinical studies and the technological improvement in the product pipeline has addressed the adoption barrier and reimbursement coverage based on morbidity of the patients is the first step towards increased adoption. The market trends, revenue forecasts, and competitive trends for each of the four segments are discussed in detail. The research contains data about four of the emerging cardiac devices/procedures market. Cardiac Procedures developed conventionally was to address the cardiac condition. Today, most procedures and products developed are to address the ailment of the patients that cannot be supported with conventional procedures and devices. The market dynamics of these emerging procedures and devices are greatly determined the upcoming product launches and product pipeline. The report encompasses an overview of emerging cardiac therapies with key findings. The emerging trends and technologies in the interventional cardiac sector and its potential market dynamics are also discussed. The analysis provides a roadmap for companies in cardiac sector to understand the emerging cardiac technologies and help them to prepare and stay competitive for the changing landscape of cardiac surgeries. Regions include United States and Western Europe (Germany, France, Spain, Italy, and the United Kingdom). This report provides revenue forecasts, reimbursement trends, and top company profiles of key segments such as Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Repair (TMVR), Endovascular Aortic Repair (EVAR), and Left Ventricular Assisted device (LVAD). Key questions this study will answer: What are the technological evolutions in the cardiac procedures and how will they impact the overall cardiac sector? Which are the most promising technologies in the emerging cardiac therapies? How will the cardiac companies continue to exist through product innovations or inorganic growth? What are the regulatory challenges faced by the device manufacturers? Are the cardiac products offered today meeting customer needs or is additional development needed? Tue, 20 Dec 2016 00:00:00 +0000 Global Laboratory Products Purchasing Trends, 2016 2017 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K168-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K168-01-00-00-00 Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory s purchasing process, be familiar with their laboratory s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 specified laboratory product categories: instruments, equipment, chemicals, reagents and kits, general lab supplies, plasticware, and glassware. A total of 557 decision makers qualified for and completed the survey, answering questions on purchases, budgets, top companies, and purchasing preferences. Respondents were segmented by type of laboratory: academic, biopharma, government, industrial, and clinical. Mon, 19 Dec 2016 00:00:00 +0000 Innovations in Medical Devices in UK - Medical Device TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0C-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0C-00-00 This edition of the Medical Device TOE profiles MedTech innovations from UK. The innovations profiled in this issue have predominantly been developed by start-ups or early-stage companies, with plenty of potential for commercial application within and outside UK. Featuring both products and services, these innovations pertain to markets such as clinical trial recruitment and management, non-invasive blood glucose monitoring, sleep apnea management, transdermal drug delivery, and novel wound healing materials. These developments are in line with key technology and market trends such as wearable devices, cloud computing, connected health, and remote patient monitoring. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Wearable devices, mobile health, continuous patient monitoring, remote patient monitoring, transdermal drug delivery Fri, 16 Dec 2016 00:00:00 +0000 Recent Advances across Diabetes and Obesity Management - Genetic TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-32-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-32-00-00 This edition of Genetic TOE profiles life sciences trends across diabetes and obesity management. The corresponding patent scenario is depicted along with the industry interactions. The Genetic TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Diabetes, obesity, microbiome regulator, blood glucose modulation, epigenetic regulation, insulin glargine, lixisenatide combination, GLP1-glucagon receptor agonists Fri, 16 Dec 2016 00:00:00 +0000 Diagnostics Summit 2016 Singapore http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297163689 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297163689 With 38 international speakers from diverse backgrounds, this comprehensive event provided a detailed overview of the current research, the latest innovations, the regulatory requirements, commercialisation of diagnostic innovations and market entry into Asia. Thu, 15 Dec 2016 00:00:00 +0000 UK s National Health Service in the Run Up to Brexit What to Expect When You re Expecting http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297161038 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297161038 The National Health Service (NHS) has set an ambitious goal to reach GBP 22 billion in efficiency savings by 2020. These efficiency savings are contingent on successful transition of care away from hospitals and toward primary care and long term care providers. Wed, 14 Dec 2016 00:00:00 +0000 Research and Development Initiatives in Hydrogels, Stents, Photovoltaics, Biofertilizers, and Text Analytics - Inside R&D TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-31-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-31-00-00 This edition of Inside R&D TOE profiles innovations in hydrogels, medical stents, photovoltaic energy, biofertilizers, and text analytics. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment. Keywords: Hydrogels, 3D printed biodegradable stents, customized implants, photovoltaics, biofertilizers, prokaryotic microorganisms, text analytics Fri, 9 Dec 2016 00:00:00 +0000 Orphan Drugs in North America - Drug Discovery TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0C-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0C-00-00 This edition of the Drug Discovery TOE depicts trends across orphan drugs in North America. Compared with standard drugs, orphan drugs involve fewer clinical trial issues. Typically, orphan drugs spend less time in regulatory review, comprise smaller phase III trial sizes, and are more likely to be approved by the US Food and Drug Administration (FDA) because they represent significant therapeutic advances for really unsolved problems. This and the higher chance of FDA approval makes many companies to penetrate the market. However, innovation is critical. Strategic partnerships and tactical regulatory planning that allow for optimizing budgets and exploiting research and clinical expertise are crucial for development success. Some companies innovating in this field and the patent scenario are depicted in this TOE. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Orphan drugs, rare diseases, genetic diseases, clinical trials, fast-track designation, breakthrough therapy designation, lysosomal storage disorders, post-transcriptional control processes, synthetic retinoid products Fri, 9 Dec 2016 00:00:00 +0000 Start-ups across the Life Sciences Industry - Genetic TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-31-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-31-00-00 This edition of Genetic Technology TOE profiles life sciences trends in start-ups across the life science industry. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Point-of-care enzymes, nutritional health, serine hydrolases, drug development, neuropsychiatric conditions, RNA-based medicines Fri, 9 Dec 2016 00:00:00 +0000 Hospital Sterilisation Outsourcing Business Set for Growth? http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297150672 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297150672 The current decade is marked by tremendous improvements and novel technology innovations in the global healthcare delivery systems. While developed nations lead the way in attaining the next level in healthcare delivery, most of the emerging economies Thu, 8 Dec 2016 00:00:00 +0000 Donald Trump and the Future of the Affordable Care Act http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297136756 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297136756 Interlocking provisions of the ACA make repeal of even targeted provisions a tricky prospect Fri, 2 Dec 2016 00:00:00 +0000 Startup Companies across the Life Sciences Industry - Genetic TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-30-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-30-00-00 This edition of Genetic Technology TOE profiles across startup companies across the life sciences industry. The corresponding patent scenario is also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Startup companies, life sciences, protein degradation, proteolysis-targeting chimeras, drug accelerators, rare diseases, small molecule solutions, blood-based disorders, non-opioid pain management solutions, chronic pain Fri, 2 Dec 2016 00:00:00 +0000 Russian Hospitals Landscape http://www.frost.com/prod/servlet/sublib/display-report.do?id=MA47-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MA47-01-00-00-00 The report provides an overview of the Russian Hospital system, listing key regions and their hospitals landscapes. Key hospitals have been profiled for the regions, with details about their infrastructure, patient trends, department trends, and other relevant information. The regions selected include Moscow, St. Petersburg, Tyumen, Krasnodar, and Rostov-on Don. The total number of hospital beds by type is also discussed for each region. Other details provided include location, type of hospital, clinical specialties, and the installed base of capital equipment (on best effort basis). Fri, 2 Dec 2016 00:00:00 +0000 Smart Pills and Ingestible Sensors - Future Tech TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D835-00-14-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D835-00-14-00-00 This Future Tech TOE depicts trends across smart pills and ingestible sensors. Endoscopic imaging, real-time sensing, targeted drug delivery, and surgery appear as the key applications and areas of growth. Drivers and challenges, convergence of innovation, global adoption, intellectual property trends and market support are also illustrated. The corresponding patent scenario is depicted along with the industry interactions. The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world. The need for low power, smaller, lighter sensors with enhanced performance attributes and minimal false alarms is driving innovations in the sensors space. The Sensors and Instrumentation cluster covers innovations pertaining to technologies such as wireless sensors and networks, energy harvesting, haptics and touch, MEMS and nanosensors, Terahertz, ubiquitous/smart sensors, CBRNE, quantified-self, sensor fusion, M2M communications, and drones. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Smart pills, ingestible sensors, diagnostic imaging, vital signs monitoring, targeted drug delivery, next generation surgery Fri, 2 Dec 2016 00:00:00 +0000 mHealth Transforming Healthcare: Ensuring the Path to the Internet of Medical Things (IoMT) http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297129503 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297129503 Mobile health (mHealth) is a technology-based capability that can connect a patient to healthcare providers regardless of the patient s location. mHealth offers the ability to overcome many obstacles that may limit other innovative connected health services. Wed, 30 Nov 2016 00:00:00 +0000 Third Party Sterilization Services for Care Providers in the US and Western Europe, Forecast to 2022 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0FE-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0FE-01-00-00-00 The study covers current and future market trends, drivers, and challenges in outsourcing of hospital sterile processing departments (SPD)/central sterile supply departments (CSSD) to specialized third party vendors. Despite being in the nascent phase, the third party sterilization services market generated total revenue of $1.4 billion in 2015 and is expected to register a CAGR of 11.4% during the 2015 to 2022. Apart from providing a segment-wise breakdown of market size and market penetration, the study also provides an overview of the current health infrastructure, CSSD resources, and regulatory environment in the countries of scope. A snapshot of key influencers and decision makers driving the adoption of third party services across countries and the different service model innovations adopted by the existing vendors are also provided. It also provides a futuristic strategic overview for D&S equipment manufacturers or OEMs to combat the increasing penetration of sterilization services and dwindling growth opportunities due to a replacement driven equipment market. Effectively, the study provides answers to what is driving the transformation from a product centric to a service-based strategy for the OEMs.--BEGIN PROMO--

Key competitors in the market include STERIS and Synergy Health, Getinge, Matachana Group, Servizi Italia, Servizi Ospedalieri, Cleanpart Healthcare, Sterience, IHSS, B. Braun Sterilog, BMI Hospital Decontamination Limited, Sterilog Gmbh, Malysse-Sterima, Combi-Ster, Cisa Infection Control, Steritalia, Clordisys Solutions, and Unity Health Trust.
 
The study analyzes the US and Western European market. The scope includes the following countries: the US, Germany, the UK, France, Spain, Italy, Benelux (Belgium, the Netherlands, and Luxembourg) and Scandinavia (Norway, Sweden, Finland, and Denmark).

Key questions the study will answer:

  • What is the current market size and penetration of third party sterilization services?
  • What are the different service models operating in the third-party sterilization services market? What are the future directions?
  • What is driving the transformation of sterilization equipment manufacturers from a product centric to a service-based model of operation?
  • Who are the key decision makers and influencers in hospitals that are driving the adoption of service-based models?
  • Are the products/services offered today meeting hospital needs or is additional development needed?
  • Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level?
Wed, 30 Nov 2016 00:00:00 +0000
Keeping Up with Telehealth http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297124720 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297124720 There is no one definition of telehealth. Some sources prefer the term telemedicine, while others use telehealth. The common aspects of any definition tend to agree about the tele part. This portion of the word is clearly spelling out that some kind of telecommunications is involved. Tue, 29 Nov 2016 00:00:00 +0000 An Outlook on Biotech Pharmaceuticals Market in Turkey http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297122992 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297122992 For the pharmaceutical industry, the 20th century was the golden era for small molecules market. Pharmaceutical companies thrived with profits generated through simple compounds and patenting them. Mon, 28 Nov 2016 00:00:00 +0000 2025 Roadmap for India Biotech Industry http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297123088 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297123088 India s biotechnology industry has been built on four core beliefs: entrepreneurship, innovation, developing local talent, and demonstrating high quality value based care. Mon, 28 Nov 2016 00:00:00 +0000 Western Europe Hospital Information Technology Outlook, 2016 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC03-01-00-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC03-01-00-00-00 This study aims to analyse and forecast the Western European Hospital Information Technology (IT) market outlook for 2016 2020. Western European hospital IT market is expected to reach a revenue of $10.72 billion in 2020, growing at a CAGR of over 5.1% from 2016 to 2020. Research Scope This research analyses various healthcare information technology (IT) products and solutions available in the market, such as healthcare provider-centric solutions, healthcare payer solutions, and hospital-based administrative and financial services. Healthcare IT vendors, medical OEMs, and mobility solution vendors can use this research to better understand the expanding role of eHealth technologies and healthcare digitisation solutions within a rapidly evolving hospital IT ecosystem. Market Trends: Key healthcare IT solutions such as eHealth, telehealth, telecare, remote monitoring, medical device connectivity, PHM, digital patient engagement, integrated care, healthcare data analytics, and business intelligence solutions. Regional Trends: United Kingdom, Germany, France, Italy, Spain, Scandinavia (Sweden, Denmark, and Norway) and Benelux (Belgium, the Netherlands, and Luxembourg). Analysis by market segment, hospital IT applications, business models, competitive landscape, and key companies to watch. Western European hospital IT market is witnessing a strong growth owing to increased adoption of hospital-centric IT systems to comply with regulatory guidelines. The growth in the industry can be ascribed to government initiatives and increased funding towards healthcare digitisation to reform existing traditional healthcare practices. Convergence of health ICT with emerging digital health solutions is expected to have a significant impact across Western Europe. Ever-increasing consumer demand for healthcare transparency and the need for cost-effective solutions are expected to fuel health informatics industry over the forecast period. Furthermore, the introduction of smart eHealth solutions, cloud computing, and standards-based interoperable systems will serve as growth factors for the Western European hospital IT market. With the increasing need for remote healthcare solutions, vendors across the globe are shifting their focus to digital health technologies so that products and services can be commercialised. Key Questions This Study Will Answer 1. Is the Western European hospital IT market growing, how long will it continue to grow, and at what rate? What is the future potential of the market? 2. How does the healthcare providers landscape look like? What are the important factors that influence the adoption of hospital IT products and services in the end-user base? 3. What are the key market drivers and restraints impacting the growth opportunities in the Western European hospital IT market? 4. What is the regional landscape for the hospital IT market in Western Europe? How do government spending, healthcare regulations, policies, and so on affect the market? 5. Are the hospital IT products/services offered today meeting end-user needs or is additional development needed? 6. Who are the major market participants in the Western European market for hospital IT, and what are their major service/product offerings and business models? Mon, 28 Nov 2016 00:00:00 +0000 Key Innovation Profiles in Medical Image Management and Informatics - Medical and Diagnostic Imaging TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-0E-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-0E-00-00 This edition of the Medical and Diagnostic and Imaging TOE depicts an end-to-end medical image management solution for hospitals, evidence-based quantitative information for lung disorders, training computers to detect rare medical conditions, automated breast mass detection, integrated workflow solution for remote access to cardiology images, and more. Insights on future growth prospects for each of the innovation spotlight are also depicted along with the industry interactions. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Medical image management solution, lung disorders, clinical decision support solutions, integrated workflow solution, deep learning platforms, data management software Fri, 25 Nov 2016 00:00:00 +0000 Advances across Oncology - Genetic Technology TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-2F-00-00 http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-2F-00-00 This edition of Genetic Technology TOE profiles trends across oncology. Clinical trials related to gene editing and immunotherapies are illustrated in the study. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Gene editing platform, microbiome-based analyses, immuno-oncology, cancer immunotherapy Fri, 25 Nov 2016 00:00:00 +0000 5 Ways Retailers Are Going to Change Your Healthcare Experience http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297105999 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297105999 In the age of healthcare consumerism, it should not come as a surprise that retailers such as Walmart and CVS are poised to change how we seek and receive a wide spectrum of care services. Tue, 22 Nov 2016 00:00:00 +0000